Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

Cambridge

Spectral Flow Cytometry Symposium 2025

The Spectral Flow Cytometry Symposium is designed to provide delegates with a highly interactive and engaging experience. Attendees will benefit from presentations by leading international [...]

Go to Top